Search

everythinglearnresearchcommunity

for

Search:↓

High-frequency ultrasonography can be a useful tool for diagnosing different stages of alopecia areata, a type of hair loss.

Four genes are potential markers for hair loss condition alopecia areata, linked to a specific type of cell death.

Tiny particles from umbilical cord stem cells may help hair grow back in a type of hair loss.

A girl with a rare genetic condition affecting hair and nails also developed a common type of hair loss, suggesting a possible genetic link.

COVID-19 infection or vaccination may influence the development of alopecia areata, a type of hair loss.

Men with male pattern baldness have a higher chance of heart disease, especially if they're younger or have severe baldness; no link was found with another type of baldness called alopecia areata.

Patients generally feel positive about alopecia areata treatments, but emotions vary by treatment type.

The document concludes that more research is needed to confirm if COVID-19 vaccines cause a type of hair loss called alopecia areata.

Blocking interferon-gamma helps prevent and treat hair loss in Alopecia Areata.

Children with alopecia areata often have low vitamin D, especially if they have darker skin, it's not summer, or they're not White.

Plasmacytoid dendritic cells are a key factor in causing hair loss in alopecia areata and could help differentiate it from other hair loss conditions.

Specific RNA patterns are linked to alopecia areata.

The document concludes that a new questionnaire to assess mental health in alopecia patients shows low rates of seeking mental health services and support groups.

Topical immunotherapy for alopecia areata may work by creating immune cell clusters in the skin.

Cytotoxic T cells cause hair loss in chronic alopecia areata.

Metformin, usually used for diabetes, can also help treat hair loss from alopecia areata due to its ability to reduce inflammation and stimulate new hair growth.

New treatments for alopecia areata show promise, but more research is needed to confirm their effectiveness.

A mutation in the KRT82 gene is significantly associated with Alopecia Areata.

Plasmacytoid dendritic cells, which overproduce IFN-α, may play a crucial role in starting alopecia areata, an autoimmune disease causing hair loss.

ILC1 cells contribute to hair loss in alopecia areata.

Minoxidil and finasteride are the only FDA-approved treatments for hair loss caused by genetic and hormonal factors, but their effectiveness is often doubted, indicating a need for new treatments.

ILC1-like cells can cause alopecia areata by attacking hair follicles.

Alopecia areata is the most common type of baldness treated with corticosteroids and minoxidil.

The document concludes that certain rats and mice are useful for studying hair loss in humans and testing treatments.

A patient with Alopecia Areata had complete hair regrowth after using the drug baricitinib.

Understanding the genetics of alopecia areata could lead to better treatments.

Targeting Vδ1+T-cells may help treat alopecia areata.

The health of the gut may be important in developing new ways to prevent, diagnose, and treat alopecia areata.

Alopecia areata can regrow hair in a pattern similar to androgenetic alopecia.

Low dose valproic acid treatment caused hair loss in a young patient.